Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

First Tracks climbs on ‘impressive’ celiac study data

Initial study findings strengthened some analysts’ belief that First Tracks’ drug, one of a few in development aimed at the protein CD122, might have “pipeline-in-a-product” potential.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at biopharmadive.com →

More in Health & Medicine

Sauna research gathers steam

Leading researchers in heat exposure are coming together to reach a consensus on what we know — and don't — about the health benefits of sauna and its potential for treating and preventing disease.

More from Monday 12 October →